RT Man Bekken 2 2015

Radiation boost lowers risk of prostate cancer recurrence


An additional external-beam radiation dose delivered directly to the tumor can benefit the prospects of men with non-metastatic prostate cancer, without causing additional side effects. The risk of relapse within five years for these men is smaller than for men who did not receive this boost, as shown by a large-scale study initiated by UMC Utrecht in collaboration with the Netherlands Cancer Institute, UZ Leuven and Radboudumc.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.